Wednesday, October 5, 2022

Lobular Breast Cancer Alliance

 


I had a less common type of breast cancer than the standard ductal/no special type: invasive lobular carcinoma (ILC).

It represents 15% of breast cancers, but only 0.5% of breast cancer research published annually. At that rate, there's little hope that if I have a recurrence in my lifetime that there will be a breakthrough to save me. 

LBCA - the Lobular Breast Cancer Alliance - is the only advocacy organization in the US dedicated to improving detection, treatment, and research into ILC. As a board member, I can speak to their efforts personally, and have seen the results of their grants, patient advocacy, and research agenda advance the cause immensely. 

I'll be racing my last triathlon of the year in Kingman, AZ on Oct. 22 (more later on that) - it's for cancer survivors, and I am raising funds for LBCA. Please consider a donation if you want to make a direct impact in the lives of lobular breast cancer patients. 

https://lobularbca.wedid.it

#invasivelobularcarcinoma #lobularbreastcanceralliance#lobularbreastcancerawareness #ihavelobularbreastcancer#thinkbeforeyoupink #fundraisingforresearch

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Aromatase Inhibitors, the "Hormone Blocker": 3 years on....

In my patient support groups and online social breast cancer circles, I read many comments a day asking about whom has chosen to take these,...